Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 446

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial

Holm, Niels R, Mäkikallio, Timo, Lindsay, M Mitchell, Spence, Mark S, Erglis, Andrejs, Menown, Ian B A, Trovik, Thor, Kellerth, Thomas, Kalinauskas, Gintaras, Mogensen, Lone Juul Hune, Nielsen, Per H, Niemelä, Matti, Lassen, Jens F, Oldroyd, Keith, Berg, Geoffrey, Stradins, Peteris, Walsh, Simon J, Graham, Alastair N J, Endresen, Petter C, Fröbert, Ole, Trivedi, Uday, Anttila, Vesa, Hildick-Smith, David, Thuesen, Leif, Christiansen, Evald H, Holm, Niels R, Mäkikallio, Timo, Lindsay, Mitchell, Spence, Mark S, Erglis, Andrejs, Menown, Ian B A, Trovik, Thor, Eskola, Markku, Romppanen, Hannu, Kellerth, Tholmas, Jensen, Lisette O, Kalinauskas, Gintaras, Linder, Rikard B A, Pentikainen, Markku, Hervold, Anders, Banning, Adrian, Zaman, Azfar, Cotton, James, Eriksen, Erlend, Margus, Sulev, Mogensen, Lone J H, Nielsen, Per H, Niemelä, Matti, Kervinen, Kari, Lassen, Jens F, Oldroyd, Keith, Berg, Geoff, Walsh, Simon J, Hanratty, Colm G, Kumsars, Indulis, Stradins, Peteris, Steigen, Terje K, Fröbert, Ole, Graham, Alastair NJ, Endresen, Petter C, Corbascio, Matthias, Kajander, Olli, Trivedi, Uday, Hartikainen, Juha, Anttila, Ves, Hildick-Smith, David, Thuesen, Leif, Christiansen, Evald H · 2020 · The Lancet

Abstract

BACKGROUND Percutaneous coronary intervention (PCI) is increasingly used in revascularisation of patients with left main coronary artery disease in place of the standard treatment, coronary artery bypass grafting (CABG). The NOBLE trial aimed to evaluate whether PCI was non-inferior to CABG in the treatment of left main coronary artery disease and reported outcomes after a median follow-up of 3·1 years. We now report updated 5-year outcomes of the trial. METHODS The prospective, randomised, open-label, non-inferiority NOBLE trial was done at 36 hospitals in nine northern European countries. Patients with left main coronary artery disease requiring revascularisation were enrolled and randomly assigned (1:1) to receive PCI or CABG. The primary endpoint was major adverse cardiac or cerebrovascular events (MACCE), a composite of all-cause mortality, non-procedural myocardial infarction, repeat revascularisation, and stroke. Non-inferiority of PCI to CABG was defined as the upper limit of the 95% CI of the hazard ratio (HR) not exceeding 1·35 after 275 MACCE had occurred. Secondary endpoints included all-cause mortality, non-procedural myocardial infarction, and repeat revascularisation. Outcomes were analysed in the intention-to-treat population. This trial is registered with ClinicalTrials.gov, NCT01496651. FINDINGS Between Dec 9, 2008, and Jan 21, 2015, 1201 patients were enrolled and allocated to PCI (n=598) or CABG (n=603), with 17 subsequently lost to early follow-up. 592 patients in each group were included in this analysis. At a median of 4·9 years of follow-up, the predefined number of events was reached for adequate power to assess the primary endpoint. Kaplan-Meier 5-year estimates of MACCE were 28% (165 events) for PCI and 19% (110 events) for CABG (HR 1·58 [95% CI 1·24-2·01]); the HR exceeded the limit for non-inferiority of PCI compared to CABG. CABG was found to be superior to PCI for the primary composite endpoint (p=0·0002). All-cause mortality was estimated in 9% after PCI versus 9% after CABG (HR 1·08 [95% CI 0·74-1·59]; p=0·68); non-procedural myocardial infarction was estimated in 8% after PCI versus 3% after CABG (HR 2·99 [95% CI 1·66-5·39]; p=0·0002); and repeat revascularisation was estimated in 17% after PCI versus 10% after CABG (HR 1·73 [95% CI 1·25-2·40]; p=0·0009). INTERPRETATION In revascularisation of left main coronary artery disease, PCI was associated with an inferior clinical outcome at 5 years compared with CABG. Mortality was similar after the two procedures but patients treated with PCI had higher rates of non-procedural myocardial infarction and repeat revascularisation. FUNDING Biosensors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(19)32972-1

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 446

Metadata

Authors
Holm, N. R., Mäkikallio, T., Lindsay, M. M., Spence, M. S., Erglis, A., Menown, I. B. A., Trovik, T., Kellerth, T., Kalinauskas, G., Mogensen, L. J. H., Nielsen, P. H., Niemelä, M., Lassen, J. F., Oldroyd, K., Berg, G., Stradins, P., Walsh, S. J., Graham, A. N. J., Endresen, P. C., Fröbert, O., Trivedi, U., Anttila, V., Hildick-Smith, D., Thuesen, L., Christiansen, E. H., Holm, N. R., Mäkikallio, T., Lindsay, M., Spence, M. S., Erglis, A., Menown, I. B. A., Trovik, T., Eskola, M., Romppanen, H., Kellerth, T., Jensen, L. O., Kalinauskas, G., Linder, R. B. A., Pentikainen, M., Hervold, A., Banning, A., Zaman, A., Cotton, J., Eriksen, E., Margus, S., Mogensen, L. J. H., Nielsen, P. H., Niemelä, M., Kervinen, K., Lassen, J. F., Oldroyd, K., Berg, G., Walsh, S. J., Hanratty, C. G., Kumsars, I., Stradins, P., Steigen, T. K., Fröbert, O., Graham, A. N., Endresen, P. C., Corbascio, M., Kajander, O., Trivedi, U., Hartikainen, J., Anttila, V., Hildick-Smith, D., Thuesen, L., & Christiansen, E. H.
Venue
The Lancet
Publisher
Elsevier BV
Published
2020-01
Volume
395
Issue
10219
Pages
191-199
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2994638107
Cited by
446
References
24
FWCI
51.42
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial. https://app.cochat.ai/papers/10.1016/s0140-6736(19)32972-1
The paper
Holm, N. R., Mäkikallio, T., Lindsay, M. M., Spence, M. S., Erglis, A., Menown, I. B. A., Trovik, T., Kellerth, T., Kalinauskas, G., Mogensen, L. J. H., Nielsen, P. H., Niemelä, M., Lassen, J. F., Oldroyd, K., Berg, G., Stradins, P., Walsh, S. J., Graham, A. N. J., Endresen, P. C., . . . Christiansen, E. H. (2020). Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial. The Lancet. https://doi.org/10.1016/s0140-6736(19)32972-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.